Vol. 4 No. 2 (2026), Articles
Vol. 4 No. 2 (2026)

СУРУНКАЛИ ЮРАК ЕТИШМОВЧИЛИГИДА КОНГЕСТИВ ҲОЛАТ ФОНИДА БУЙРАК ФУНКЦИЯСИ БУЗИЛИШИНИ ЭРТА ПРОГНОЗЛАШ

Articles
Published 2026-02-14
Исмоилов Акмал Тўраевич
Бухоро давлат тиббиёт институти
PDF
DOI

Keywords

сурункали юрак етишмовчилиги, веноз конгестия, кардиоренал синдром, цистатин C, NT-proBNP, eGFR.

How to Cite

СУРУНКАЛИ ЮРАК ЕТИШМОВЧИЛИГИДА КОНГЕСТИВ ҲОЛАТ ФОНИДА БУЙРАК ФУНКЦИЯСИ БУЗИЛИШИНИ ЭРТА ПРОГНОЗЛАШ. (2026). MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE, 4(2), 104-112. https://universalpublishings.com/~niverta1/index.php/mpttp/article/view/16717
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Сурункали юрак етишмовчилиги (СЮЕ)да веноз конгестия буйрак функциясига салбий таъсир кўрсатиб, кардиоренал синдром (КРС) шаклланишини тезлаштиради. Ушбу тадқиқотда СЮЕ билан оғриган 96 нафар беморда конгестив гемодинамиканинг буйрак функциясига таъсири баҳоланди ва эрта лаборатор маркерлар аҳамияти аниқланди. 

PDF
DOI

References

1. McDonagh T.A., Metra M., Adamo M. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3599–3726.

2. Rangaswami J., Bhalla V., Blair J.E.A. et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies. AHA Scientific Statement. 2019.

3. Damman K., Valente M.A.E., Voors A.A. et al. Renal impairment, worsening renal function, and outcome in patients with heart failure. European Heart Journal. 2014;35:455–469.

4. Mullens W., Abrahams Z., Francis G.S. et al. Importance of venous congestion for worsening renal function in advanced decompensated heart failure. Journal of the American College of Cardiology. 2009;53(7):589–596.

5. Testani J.M., Kimmel S.E., Dries D.L. et al. Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy. Circulation. 2011;124:120–129.

6. Ronco C., Haapio M., House A.A. et al. Cardiorenal syndrome. Journal of the American College of Cardiology. 2008;52(19):1527–1539.

7. Tang W.H.W., Mullens W. Cardiorenal syndrome in decompensated heart failure. Heart. 2010;96:255–260.

8. Shlipak M.G., Mattes M.D., Peralta C.A. Update on cystatin C: incorporation into clinical practice. American Journal of Kidney Diseases. 2013;62(3):595–603.

9. KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements. 2013;3(1):1–150.

10. Januzzi J.L., Ahmad T., Mulder H. et al. Natriuretic peptides for the diagnosis and management of heart failure. JACC. 2019;73(5):634–646.

11. House A.A., Wanner C., Sarnak M.J. et al. Heart failure in chronic kidney disease: conclusions from a KDIGO Controversies Conference. Kidney International. 2019;95:1304–1317.

12. Boorsma E.M., Ter Maaten J.M., Voors A.A. Renal biomarkers in heart failure. European Journal of Heart Failure. 2020;22(3):360–372.